Curated News
By: NewsRamp Editorial Staff
August 04, 2026
LR Health & Beauty Confirms 2025 Results, Invests €2M in Production
TLDR
- LR Health & Beauty confirms 2025 figures and invests 2 million euros in a new production line to gain a strategic edge.
- LR's final 2025 report shows sales of 277.1 million euros and EBITDA of 16.5 million, with a 2 million euro investment in a high-capacity production line.
- LR's investment in in-house production and commitment to partners supports sustainable growth, benefiting communities through its global fund for disadvantaged children.
- LR is centralizing production of its 5in1 products in Ahlen, with a new line capable of making up to 40 million units annually.
Impact - Why it Matters
This news matters for investors, partners, and consumers of LR Health & Beauty products. The confirmation of financial results provides transparency on the company's performance, while the investment in new production capacity signals confidence in future growth and innovation. For the industry, it highlights the ongoing trend of social commerce companies investing in in-house manufacturing to enhance quality and efficiency. For consumers, it ensures continued availability and potential improvements of popular products like the 5in1 line, and underscores LR's commitment to sustainable practices.
Summary
LR Health & Beauty SE, Europe's leading social commerce company for high-quality nutritional supplements and beauty products, has published its final annual report for 2025, confirming preliminary sales and EBITDA figures. The LR Group generated sales of EUR 277.1 million in 2025, down from EUR 289.2 million in 2024. Reported EBITDA was EUR 16.5 million, impacted by one-off effects from the reorganization of its financing structure, while normalized EBITDA stood at EUR 22.5 million (2024: EUR 32.6 million). CEO Jorg Korfer emphasized that 2026 is a transitional year, with the company laying groundwork for sustainable growth and continuing strategic initiatives in production, logistics, and sales.
A key strategic pillar is expanding in-house production. LR is investing over 2 million euros in a new high-performance production line to centralize the manufacture of its 5in1 product category, including the established LR 5in1 Beauty Elixir and LR 5in1 Men's Shot, at its site in Ahlen. The new facility will have an annual capacity of up to 40 million units, paving the way for further product innovations in nutritional supplements. The full 2025 Annual Report is available on the company's website at https://ir.lrworld.com.
Founded in 1985 and headquartered in Ahlen, Germany, LR operates in 32 countries, producing and distributing nutritional supplements and cosmetics under the motto "More quality for your life." The company's social commerce model leverages digital solutions like the "LR neo" dashboard to support its community. With over 20 years of expertise in aloe vera processing, LR operates one of Europe's most modern aloe vera production facilities. Additionally, the LR Global Kids Fund, established in 2009, supports disadvantaged children worldwide. For more on their sustainability efforts, readers can access their Sustainability Report.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, LR Health & Beauty Confirms 2025 Results, Invests €2M in Production
